Search

everythinglearnresearchcommunity

for

Search:↓

Mental and social factors greatly affect skin conditions and doctors find it hard to deal with these aspects.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Telemedicine is effective for sexual medicine consultations.

Cyproterone acetate improves skin symptoms and quality of life in women with androgen-related issues.

Cognitive-behavioral therapy is the best treatment for hair-pulling disorder, and combining it with other therapies could improve results.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document discusses a young boy with autism and early puberty but does not provide a conclusion on managing his behavior.

Adding aripiprazole to the treatment improved hair-pulling symptoms in a teenager.

The therapies improved ejaculation disorders and sexual function in middle-aged men.

New methods for identifying and managing polycystic ovary syndrome in teenagers are improving.

Pediatricians should advise sexually active teens on safe sex and STD prevention, and discuss contraceptive options and their side effects.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

Gender-affirming care greatly improves mental health for transgender and non-binary individuals.

Gender-affirming hormone therapy in South Korea aligns with international guidelines and has specific side effects.

Hormonal therapy in adults with gender dysphoria often leads to skin issues like acne, requiring a team of skin and hormone doctors.

Some alternative therapies might help treat eating disorders when combined with standard care, but more research is needed to confirm their safety and effectiveness.

The document suggests using trazodone and clomiphene to treat sexual dysfunction caused by post-finasteride syndrome.

Transgender and gender-diverse teens need specialized skin and mental health care.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Childhood sexual trauma, especially between ages 5-7, is linked to lower cortisol levels in adult hair, suggesting long-term stress response changes.

Gender-affirming dermatology treatments generally improve mental well-being for transgender individuals, but more research is needed.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by blocking male sex hormones.

Treating hematospermia can improve sexual function and reduce anxiety.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Hormonal therapy in transgender patients can lead to skin changes like altered sebum production, hair growth, and acne, which may require dermatological care.

The document concludes that personalized treatment, including lifestyle changes and medication, is essential for managing PCOS in teenagers, while also addressing their psychological well-being.

The document concludes that pediatricians play a vital role in supporting adolescents through puberty and should enhance their competence in this area.

Endocrine therapy helps with reproductive and metabolic issues in women with PCOS.

A boy's early puberty caused by a testicular tumor returned to normal after surgery.